B7-H3

B7-H3

B7-H3 Overview

Molecule Name
CD276 antigen
Synonyms
B7-H3,CD276,B7 homolog 3
Drug Development Progress
Drugs in Clinical Trials72
Approved Drugs0
Highest Development StageNDA/BLA
Target Synonym
B7 homolog 3,PSEC0249,UNQ309/PRO352,B7-H3,CD276 antigen,B7H3,CD276,CD276 Molecule,Costimulatory Molecule,4Ig-B7-H3,B7RP-2
Background
B7 homolog 3 (B7-H3), a member of the immunoglobulin superfamily, is also known CD276, which contains two Ig-like C2-type (immunoglobulin-like) domains and two Ig-like V-type (immunoglobulin-like) domains. B7-H3 may participate in the regulation of T-cell-mediated immune response. B7-H3 also plays a protective role in tumor cells by inhibiting natural-killer mediated cell lysis as well as a role of marker for detection of neuroblastoma cells. Furthermore, B7-H3 is involved in the development of acute and chronic transplant rejection and in the regulation of lymphocytic activity at mucosal surfaces. It could also play a key role in providing the placenta and fetus with a suitable immunological environment throughout pregnancy.

B7-H3 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

How can ACROBiosystems B7-H3 proteins support B7-H3-targeted research?

How should biotinylated and fluorescently labeled B7-H3 proteins be selected for different assays?

Which B7-H3 protein formats are suitable for antibodies targeting different epitopes?

Which B7-H3 protein format is suitable for antibody screening and binding characterization?

What is the difference between B7-H3 (2Ig) and B7-H3 (4Ig) proteins?